Trial Condition(s):
Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea
Assessment of pharmacokinetics of Azelaic Acid Foam after repeated skin application and in comparison to Azelaic Acid gel.
Assessment of safety after repeated skin application.
- diagnosis of moderate papulopustular rosacea - free of any clinically significant disease
- body weight less than 50 or more than 130 kg - clinically significant disease which could interfere with the study
Locations | Status | ||
---|---|---|---|
Locations Novum Pharmaceutical Research Services of Nevada Inc. Las Vegas, United States, 89121 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Investigator-blinded, Randomized, Cross-over, Multiple Dose Phase I Study on Safety and Pharmacokinetics of Topically Applied Azelaic Acid Foam, 15% Compared to Azelaic Acid Gel, 15% in Subjects With Papulopustular Rosacea
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Treatment
Allocation:
Randomized
Blinding:
Single Blind
Assignment:
Crossover Assignment
Trial Arms:
2